Laboratorios Farmaceuticos Rovi, S.A.

LABFFOTCHealthcare● Active

$90.61

+$0.00(+0.00%)

Market Cap$4.6B

P/E Ratio—

52W High$90.61

52W Low$90.61

Avg Volume53.6

Open$90.61

Beta0.22

Net Income Financials Revenue

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

LABFF · net income · updated Jun 9, 2026

Core profitability metrics

LABFF · net income · margin · TTM · CAGR

Net income was $140.4M for FY2025 (fiscal year ending 2025-12-31), up 2.6% year-over-year. Net profit margin was 18.9%. Based on available data, Laboratorios Farmaceuticos Rovi, S.A. has been profitable since at least 2011.

FY2025 Net Income$140.4M▲ +2.6% YoY

Trailing 12M (TTM)$131.8Mtrailing 4 quarters sum

Net Profit Margin18.9%$140.4M ÷ $743.2M

YoY Change+2.6%—

5-Year CAGR+18.1%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · LABFF net income history · LABFF profit margin

Annual net income data

LABFF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$140.4M▲ +2.6%18.9%$743.2M

FY2024$136.9M▼ 19.6%17.9%$763.7M

FY2023$170.3M▼ 14.7%20.5%$829.5M

FY2022$199.7M▲ +30.4%24.4%$817.7M

FY2021$153.1M▲ +150.7%23.6%$648.7M

Net income vs peers (Healthcare)

LABFF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Laboratorios Farmaceuticos Rovi, S.A.YOU

LABFF

$140.4M+2.6%18.9%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) reported net income of $140.4M for FY2025 (fiscal year ending 2025-12-31), up 2.6% year-over-year. The net profit margin was 18.9% — meaning the company kept $0.19 of every dollar of revenue as profit.

Based on available data, Laboratorios Farmaceuticos Rovi, S.A. has been profitable since at least 2011. Net income reached a peak of $199.7M in FY2022. Data available for 15 fiscal years.

Laboratorios Farmaceuticos Rovi, S.A.'s net profit margin was 18.9% for FY2025, based on the latest annual results.

Investors sometimes search for "Laboratorios Farmaceuticos Rovi, S.A. net worth" — the company's market capitalization is a separate figure from LABFF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

LABFF net income · 5 questions

Laboratorios Farmaceuticos Rovi, S.A. is profitable. The company reported net income of $140.4M for FY2025, a net profit margin of 18.9%. Net income was up 2.6% year-over-year. Based on available data, Laboratorios Farmaceuticos Rovi, S.A. has been profitable since at least 2011.

is LABFF profitabledoes LABFF make a profitLABFF profitabilityLABFF profitable company

▸ Source: FMP /income-statement · GAAP · Laboratorios Farmaceuticos Rovi, S.A. · Laboratorios Farmaceuticos Rovi, S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026